These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31383037)

  • 1. Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function.
    Ulbar F; Montemurro T; Jofra T; Capri M; Comai G; Bertuzzo V; Lavazza C; Mandelli A; Viganò M; Budelli S; Bacalini MG; Pirazzini C; Garagnani P; Giudice V; Sollazzo D; Curti A; Arpinati M; La Manna G; Cescon M; Pinna AD; Franceschi C; Battaglia M; Giordano R; Catani L; Lemoli RM
    J Transl Med; 2019 Aug; 17(1):250. PubMed ID: 31383037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human LAP
    Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
    Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35.
    Ulbar F; Villanova I; Giancola R; Baldoni S; Guardalupi F; Fabi B; Olioso P; Capone A; Sola R; Ciardelli S; Del Papa B; Brattelli A; Ricciardi I; Taricani S; Sabbatinelli G; Iuliani O; Passeri C; Sportoletti P; Santarone S; Pierini A; Calabrese G; Falzetti F; Bonfini T; Accorsi P; Ruggeri L; Martelli MF; Velardi A; Di Ianni M
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2204-2210. PubMed ID: 32961369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells.
    Dijke IE; Hoeppli RE; Ellis T; Pearcey J; Huang Q; McMurchy AN; Boer K; Peeters AM; Aubert G; Larsen I; Ross DB; Rebeyka I; Campbell A; Baan CC; Levings MK; West LJ
    Am J Transplant; 2016 Jan; 16(1):58-71. PubMed ID: 26414799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function.
    Ma X; Cao L; Raneri M; Wang H; Cao Q; Zhao Y; Bediaga NG; Naselli G; Harrison LC; Hawthorne WJ; Hu M; Yi S; O'Connell PJ
    JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37874660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
    Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
    Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of ex-vivo expanded human TCR-αβ
    Achita P; Dervovic D; Ly D; Lee JB; Haug T; Joe B; Hirano N; Zhang L
    Clin Exp Immunol; 2018 Sep; 193(3):386-399. PubMed ID: 30066399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation.
    Peters JH; Preijers FW; Woestenenk R; Hilbrands LB; Koenen HJ; Joosten I
    PLoS One; 2008 Sep; 3(9):e3161. PubMed ID: 18776930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models.
    Del Papa B; Ruggeri L; Urbani E; Baldoni S; Cecchini D; Zei T; Iacucci Ostini R; Crescenzi B; Carotti A; Pierini A; Sportoletti P; Di Bartolomeo P; Falzetti F; Mecucci C; Velardi A; Martelli MF; Di Ianni M
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1847-1851. PubMed ID: 28729148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Low Numbers of CD4
    Copsel S; Wolf D; Kale B; Barreras H; Lightbourn CO; Bader CS; Alperstein W; Altman NH; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1788-1794. PubMed ID: 29751114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
    Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
    Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
    Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
    Front Immunol; 2020; 11():181. PubMed ID: 32117306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.
    McKenna DH; Sumstad D; Kadidlo DM; Batdorf B; Lord CJ; Merkel SC; Koellner CM; Curtsinger JM; June CH; Riley JL; Levine BL; Miller JS; Brunstein CG; Wagner JE; Blazar BR; Hippen KL
    Cytotherapy; 2017 Feb; 19(2):250-262. PubMed ID: 27887864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.
    Stamou P; Marioli D; Patmanidi AL; Sgourou A; Vittoraki A; Theofani E; Pierides C; Taraviras S; Costeas PA; Spyridonidis A
    Cytotherapy; 2017 Apr; 19(4):521-530. PubMed ID: 28162915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.
    Choi J; Ritchey J; Prior JL; Holt M; Shannon WD; Deych E; Piwnica-Worms DR; DiPersio JF
    Blood; 2010 Jul; 116(1):129-39. PubMed ID: 20424188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.